Julie Grant

General Partner at Canaan Partners

Julie Papanek Grant is a General Partner at Canaan (canaan.com), where she leads biopharma investments and company formation focused on improving patient care. Since joining Canaan in 2013, she has helped build and back companies including Day One Biopharmaceuticals, Synthekine, and Nocion, drawing on earlier operating experience at Genentech bringing new oncology products to market. She serves on several boards and was appointed to the U.S. National Cancer Advisory Board in 2023. More about her background is available on LinkedIn: https://www.linkedin.com/in/julie-grant-a8961b1.